老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

15.07
+0.62004.29%
盘后：15.070.00000.00%19:02 EDT
成交量：90.25万
成交额：1,345.68万
市值：25.60亿
市盈率：-5.76
高：15.11
开：14.45
低：14.41
收：14.45
数据加载中...
总览公司新闻公告
2021/08/02

重要事件披露

8-K - Current report
2021/08/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/13

重要事件披露

8-K - Current report
2021/06/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/06/01

重要事件披露

8-K - Current report
2021/03/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/02/17

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/02

重要事件披露

8-K - Current report
2021/01/12

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/12

重要事件披露

8-K - Current report
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/18

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/18

重要事件披露

8-K - Current report
2020/09/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/31

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
更多